# Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer

> **NCT00054574** · PHASE2 · COMPLETED · sponsor: **Jonsson Comprehensive Cancer Center**

## Conditions studied

- Prostate Cancer

## Interventions

- **BIOLOGICAL:** panitumumab

## Key facts

- **NCT ID:** NCT00054574
- **Lead sponsor:** Jonsson Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-11
- **Primary completion:** 2003-09
- **Final completion:** 2004-02
- **Target enrollment:** — (—)
- **Last updated:** 2020-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00054574

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00054574, "Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00054574. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*